D.J. Marcotte

1.0k total citations
17 papers, 421 citations indexed

About

D.J. Marcotte is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, D.J. Marcotte has authored 17 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Cell Biology and 4 papers in Oncology. Recurrent topics in D.J. Marcotte's work include Microtubule and mitosis dynamics (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). D.J. Marcotte is often cited by papers focused on Microtubule and mitosis dynamics (3 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and Cytokine Signaling Pathways and Interactions (3 papers). D.J. Marcotte collaborates with scholars based in United States, Switzerland and South Korea. D.J. Marcotte's co-authors include Laura Silvian, Craig P. Wildes, Istvan Enyedy, Victor Sukbong Hong, J. Howard Jones, Robert M. Arduini, Yuting Liu, M.J. Romanowski, Elisabeth Mertsching and Brian T. Hopkins and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Protein Science.

In The Last Decade

D.J. Marcotte

17 papers receiving 412 citations

Peers

D.J. Marcotte
Chris J. Novotny United States
David J. Calderwood United States
Brian Zifcak United States
Darcy Bates United States
Jason Boggs United States
Nicolas Warin United Kingdom
Roberta Pireddu United States
Lori K. Gavrin United States
Chris J. Novotny United States
D.J. Marcotte
Citations per year, relative to D.J. Marcotte D.J. Marcotte (= 1×) peers Chris J. Novotny

Countries citing papers authored by D.J. Marcotte

Since Specialization
Citations

This map shows the geographic impact of D.J. Marcotte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.J. Marcotte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.J. Marcotte more than expected).

Fields of papers citing papers by D.J. Marcotte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.J. Marcotte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.J. Marcotte. The network helps show where D.J. Marcotte may publish in the future.

Co-authorship network of co-authors of D.J. Marcotte

This figure shows the co-authorship network connecting the top 25 collaborators of D.J. Marcotte. A scholar is included among the top collaborators of D.J. Marcotte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.J. Marcotte. D.J. Marcotte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Ericsson, Anna, David J. Richard, Erik Wilker, et al.. (2024). FT-4202, a selective pyruvate kinase R activator for sickle cell disease. Experimental Hematology. 141. 104673–104673. 1 indexed citations
2.
Ma, Bin, Lei Zhang, Lihong Sun, et al.. (2021). Discovery of Potent Selective Nonzinc Binding Autotaxin Inhibitor BIO-32546. ACS Medicinal Chemistry Letters. 12(7). 1124–1129. 5 indexed citations
3.
Bajrami, Bekim, D.J. Marcotte, Jayanth V. Chodaparambil, et al.. (2020). Mechanisms of Regulation and Diverse Activities of Tau-Tubulin Kinase (TTBK) Isoforms. Cellular and Molecular Neurobiology. 41(4). 669–685. 13 indexed citations
4.
Marcotte, D.J., Kerri Spilker, Dingyi Wen, et al.. (2020). The crystal structure of the catalytic domain of tau tubulin kinase 2 in complex with a small-molecule inhibitor. Acta Crystallographica Section F Structural Biology Communications. 76(3). 103–108. 4 indexed citations
5.
Xin, Zhili, J. Howard Jones, Istvan Enyedy, et al.. (2020). Discovery of CNS-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors. ACS Medicinal Chemistry Letters. 11(4). 485–490. 16 indexed citations
6.
Ma, Bin, Brian S. Lucas, Andrew G. Capacci, et al.. (2019). Design, synthesis and identification of novel, orally bioavailable non-covalent Nrf2 activators. Bioorganic & Medicinal Chemistry Letters. 30(4). 126852–126852. 30 indexed citations
7.
Xin, Zhili, J. Howard Jones, Istvan Enyedy, et al.. (2019). Rational Design and Optimization of a Novel Class of Macrocyclic Apoptosis Signal-Regulating Kinase 1 Inhibitors. Journal of Medicinal Chemistry. 62(23). 10740–10756. 25 indexed citations
8.
Marcotte, D.J., Jean‐Christophe Hus, Craig P. Wildes, et al.. (2017). Lock and chop: A novel method for the generation of a PICK1 PDZ domain and piperidine‐based inhibitor co‐crystal structure. Protein Science. 27(3). 672–680. 11 indexed citations
9.
Marcotte, D.J., Yuting Liu, J. Howard Jones, et al.. (2016). Structural determinant for inducing RORgamma specific inverse agonism triggered by a synthetic benzoxazinone ligand. BMC Structural Biology. 16(1). 7–7. 23 indexed citations
10.
Enyedy, Istvan, Noel A. Powell, Justin A. Caravella, et al.. (2016). Discovery of biaryls as RORγ inverse agonists by using structure-based design. Bioorganic & Medicinal Chemistry Letters. 26(10). 2459–2463. 12 indexed citations
11.
Marcotte, D.J., Mia Rushe, Robert M. Arduini, et al.. (2016). Germinal‐center kinase‐like kinase co‐crystal structure reveals a swapped activation loop and C‐terminal extension. Protein Science. 26(2). 152–162. 16 indexed citations
12.
Banerjee, Daliya, Tonika Bohnert, Jianhua Chao, et al.. (2015). Discovery of novel pyrazole-containing benzamides as potent RORγ inverse agonists. Bioorganic & Medicinal Chemistry Letters. 25(15). 2985–2990. 27 indexed citations
13.
Goedken, Eric R., M.A. Argiriadi, David Banach, et al.. (2015). Tricyclic Covalent Inhibitors Selectively Target Jak3 through an Active Site Thiol. Journal of Biological Chemistry. 290(8). 4573–4589. 73 indexed citations
14.
Chao, Jianhua, Istvan Enyedy, D.J. Marcotte, et al.. (2015). Discovery of biaryl carboxylamides as potent RORγ inverse agonists. Bioorganic & Medicinal Chemistry Letters. 25(15). 2991–2997. 27 indexed citations
15.
Tam, Betty Y., Deping Wang, D.J. Marcotte, et al.. (2012). Structure-based design of 2,6,7-trisubstituted-7H-pyrrolo[2,3-d]pyrimidines as Aurora kinases inhibitors. Bioorganic & Medicinal Chemistry Letters. 22(12). 4033–4037. 23 indexed citations
16.
Marcotte, D.J., Yuting Liu, Robert M. Arduini, et al.. (2010). Structures of human Bruton's tyrosine kinase in active and inactive conformations suggest a mechanism of activation for TEC family kinases. Protein Science. 19(3). 429–439. 106 indexed citations
17.
Argiriadi, M.A., David Banach, D.J. Marcotte, et al.. (2009). Rational mutagenesis to support structure-based drug design: MAPKAP kinase 2 as a case study. BMC Structural Biology. 9(1). 16–16. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026